Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing
2016; Taylor & Francis; Volume: 58; Issue: 4 Linguagem: Inglês
10.1080/10428194.2016.1225208
ISSN1042-8194
AutoresCédric Pastoret, Roch Houot, Francisco Llamas‐Gutierrez, Marie‐Laure Boulland, Tony Marchand, Patrick Tas, Béatrice Ly-Sunnaram, Virginie Gandemer, Thierry Lamy, Mikaël Roussel, Thierry Fest,
Tópico(s)Vascular Tumors and Angiosarcomas
ResumoMyeloid sarcoma (MS) are extramedullary tumor masses consisting of a proliferation of myeloid immature cells that efface the underlying tissue architecture.[1] It may develop de novo or concurrentl...
Referência(s)